| Landscape and dynamics of single immune cells in hepatocellular carcinoma Q Zhang, Y He, N Luo, SJ Patel, Y Han, R Gao, M Modak, S Carotta, ... Cell 179 (4), 829-845. e20, 2019 | 1003 | 2019 |
| Th17 cells are long lived and retain a stem cell-like molecular signature P Muranski, ZA Borman, SP Kerkar, CA Klebanoff, Y Ji, L Sanchez-Perez, ... Immunity 35 (6), 972-985, 2011 | 484 | 2011 |
| Cellular constituents of immune escape within the tumor microenvironment SP Kerkar, NP Restifo Cancer research 72 (13), 3125-3130, 2012 | 452 | 2012 |
| Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma L Zhang, RA Morgan, JD Beane, Z Zheng, ME Dudley, SH Kassim, ... Clinical cancer research 21 (10), 2278-2288, 2015 | 377 | 2015 |
| IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors SP Kerkar, RS Goldszmid, P Muranski, D Chinnasamy, Z Yu, RN Reger, ... The Journal of clinical investigation 121 (12), 4746-4757, 2011 | 365 | 2011 |
| Cancer prevention and therapy through the modulation of the tumor microenvironment SC Casey, A Amedei, K Aquilano, AS Azmi, F Benencia, D Bhakta, ... Seminars in cancer biology 35, S199-S223, 2015 | 363 | 2015 |
| Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy CS Hinrichs, ZA Borman, L Gattinoni, Z Yu, WR Burns, J Huang, ... Blood, The Journal of the American Society of Hematology 117 (3), 808-814, 2011 | 363 | 2011 |
| Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics JG Crompton, M Sukumar, R Roychoudhuri, D Clever, A Gros, RL Eil, ... Cancer research 75 (2), 296-305, 2015 | 348 | 2015 |
| Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice CA Klebanoff, L Gattinoni, DC Palmer, P Muranski, Y Ji, CS Hinrichs, ... Clinical Cancer Research 17 (16), 5343-5352, 2011 | 323 | 2011 |
| Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment L Zhang, SP Kerkar, Z Yu, Z Zheng, S Yang, NP Restifo, SA Rosenberg, ... Molecular therapy 19 (4), 751-759, 2011 | 314 | 2011 |
| Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 302 | 2015 |
| Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts SP Kerkar, P Muranski, A Kaiser, A Boni, L Sanchez-Perez, Z Yu, ... Cancer research 70 (17), 6725-6734, 2010 | 293 | 2010 |
| Local delivery of lnterleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice D Chinnasamy, Z Yu, SP Kerkar, L Zhang, RA Morgan, NP Restifo, ... Clinical Cancer Research 18 (6), 1672-1683, 2012 | 285 | 2012 |
| Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6 LM Draper, MLM Kwong, A Gros, S Stevanović, E Tran, S Kerkar, ... Clinical Cancer Research 21 (19), 4431-4439, 2015 | 182 | 2015 |
| Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors S Kerkar, AM Carlin, RL Sohn, C Steffes, J Tyburski, P Littrup, D Weaver Surgery 136 (4), 770-779, 2004 | 125 | 2004 |
| Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies SP Kerkar, L Sanchez-Perez, S Yang, ZA Borman, P Muranski, Y Ji, ... Journal of immunotherapy 34 (4), 343-352, 2011 | 121 | 2011 |
| Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma S Yeh, NK Karne, SP Kerkar, CK Heller, DC Palmer, LA Johnson, Z Li, ... Ophthalmology 116 (5), 981-989. e1, 2009 | 114 | 2009 |
| Liver resections in metastatic gastric cancer SP Kerkar, CD Kemp, I Avital HPB 12 (9), 589-596, 2010 | 83 | 2010 |
| The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone SP Kerkar, CD Kemp, A Duffy, US Kammula, DS Schrump, KF Kwong, ... Trials 10, 1-8, 2009 | 82 | 2009 |
| Collapse of the tumor stroma is triggered by IL-12 induction of Fas SP Kerkar, AJ Leonardi, N Van Panhuys, L Zhang, Z Yu, JG Crompton, ... Molecular Therapy 21 (7), 1369-1377, 2013 | 76 | 2013 |
